◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › B › BRKR

Bruker Corporation (BRKR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-19

Bruker Corporation (BRKR) operates in the MEDICAL DEVICES industry and is headquartered in Billerica, United States with about 11,085 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, BRKR reported $3.4B in revenue and ($9M) in net income.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Interactive charts & full statements → Open the BRKR valuation workbench →

BRKR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$3.5B	$3.4B	$3.4B	$3.0B	$2.5B	$2.4B	$2.0B	$2.1B	$1.9B	$1.8B	$1.6B	$1.6B	$1.8B	$1.8B	$1.8B	$1.7B	$1.3B	$1.1B	$1.1B	$548M	$436M
Gross Profit	$1.6B	$1.6B	$1.6B	$1.5B	$1.3B	$1.2B	$940M	$995M	$900M	$813M	$742M	$709M	$763M	$805M	$831M	$752M	$606M	$519M	$505M	$253M	$199M
Gross Margin %	46.7%	45.9%	49.0%	51.0%	51.6%	50.0%	47.3%	48.0%	47.5%	46.0%	46.1%	43.6%	42.2%	43.8%	46.4%	45.6%	46.4%	46.5%	45.6%	46.2%	45.7%
Operating Income (EBIT)	$275M	$236M	$253M	$437M	$433M	$413M	$248M	$301M	$262M	$215M	$177M	$146M	$105M	$148M	$156M	$156M	$156M	$137M	$108M	$50M	$31M
Operating Margin %	7.9%	6.9%	7.5%	14.7%	17.1%	17.1%	12.5%	14.5%	13.8%	12.2%	11.0%	9.0%	5.8%	8.1%	8.7%	9.4%	11.9%	12.3%	9.8%	9.1%	7.0%
Net Income	($72M)	($9M)	$113M	$427M	$297M	$277M	$158M	$197M	$180M	$79M	$154M	$102M	$57M	$80M	$78M	$92M	$95M	$81M	$65M	$32M	$18M
Net Margin %	-2.1%	-0.2%	3.4%	14.4%	11.7%	11.5%	7.9%	9.5%	9.5%	4.5%	9.5%	6.3%	3.1%	4.3%	4.3%	5.6%	7.3%	7.3%	5.9%	5.8%	4.2%
EBITDA	—	$303M	$439M	$676M	$519M	$497M	$321M	$372M	$340M	$300M	$262M	$229M	$216M	$239M	$212M	$206M	$156M	$166M	$135M	$63M	$50M
Earnings Per Share (EPS)	—	$-0.06	$0.76	$2.90	$1.99	$1.81	$1.02	$1.26	$1.14	$0.49	$0.95	$0.60	$0.33	$0.48	$0.46	$0.55	$0.58	$0.49	$0.39	$0.19	$0.18
Shares Outstanding (M)	—	152M	150M	147M	149M	153M	155M	157M	157M	159M	162M	169M	170M	168M	167M	167M	166M	165M	166M	164M	103M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BRKR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$838M	$823M	$977M	$860M	$797M	$801M	$980M	$864M	$801M
Gross Profit	$416M	$389M	$449M	$379M	$358M	$391M	$493M	$419M	$385M
Gross Margin %	49.6%	47.3%	46.0%	44.1%	44.9%	48.8%	50.4%	48.4%	48.0%
Operating Income (EBIT)	$83M	$45M	$112M	$35M	$12M	$32M	$72M	$68M	$48M
Operating Margin %	9.9%	5.5%	11.4%	4.1%	1.5%	4.0%	7.4%	7.9%	6.0%
Net Income	($52M)	$14M	$26M	($60M)	$8M	$17M	$14M	$41M	$8M
Net Margin %	-6.2%	1.8%	2.7%	-6.9%	0.9%	2.2%	1.4%	4.7%	0.9%
EBITDA	—	$89M	$138M	$4M	$72M	$89M	$125M	$118M	$85M
Earnings Per Share (EPS)	—	$0.09	$0.17	$-0.39	$0.05	$0.11	$0.09	$0.27	$0.05
Shares Outstanding (M)	—	153M	152M	152M	152M	152M	152M	152M	148M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BRKR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$191M	$134M	$251M	$350M	$262M	$282M	$333M	$213M	$240M	$154M	$131M	$229M	$114M	$145M	$133M	$88M	$156M	$150M	$107M	$28M	$38M
Capital Expenditures (CapEx)	$97M	$120M	$115M	$107M	$119M	$92M	$98M	$73M	$49M	$44M	$37M	$34M	$34M	$50M	$73M	$54M	$32M	$16M	$47M	$16M	$8M
Free Cash Flow (FCF)	$94M	$14M	$136M	$243M	$143M	$190M	$235M	$140M	$190M	$111M	$94M	$195M	$80M	$95M	$60M	$33M	$124M	$134M	$60M	$12M	$30M
FCF Margin %	2.7%	0.4%	4.0%	8.2%	5.7%	7.9%	11.8%	6.8%	10.1%	6.3%	5.8%	12.0%	4.5%	5.1%	3.4%	2.0%	9.5%	12.0%	5.4%	2.2%	6.9%
Dividends Paid	—	$23M	$30M	$29M	$30M	$24M	$25M	$25M	$25M	$25M	$26M	$42M	$1M	$1M	$1M	$0M	$0M	—	$23M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BRKR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	($77M)	$71M	$230M	($33M)	($128M)	$65M	$190M	$38M	$1M
Capital Expenditures (CapEx)	$29M	$24M	$23M	$21M	$21M	$26M	$37M	$33M	$25M
Free Cash Flow (FCF)	($106M)	$47M	$207M	($54M)	($149M)	$39M	$153M	$6M	($24M)
FCF Margin %	-12.7%	5.7%	21.2%	-6.3%	-18.7%	4.9%	15.7%	0.7%	-2.9%
Dividends Paid	—	$19M	$18M	$0M	$8M	$8M	$8M	$8M	$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BRKR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$6.1B	$6.2B	$5.8B	$4.2B	$3.6B	$3.6B	$3.0B	$2.8B	$2.1B	$1.9B	$1.8B	$1.7B	$1.9B	$2.0B	$1.9B	$1.7B	$1.6B	$1.2B	$1.1B	$553M	$433M
Cash & Cash Equivalents	$185M	$299M	$183M	$488M	$646M	$1.1B	$682M	$678M	$322M	$325M	$342M	$267M	$320M	$439M	$311M	$246M	$230M	$207M	$166M	$73M	$52M
Total Liabilities	$3.6B	$3.7B	$4.0B	$2.8B	$2.5B	$2.6B	$2.1B	$1.8B	$1.2B	$1.2B	$1.1B	$998M	$1.1B	$1.1B	$1.1B	$1.1B	$1.0B	$753M	$804M	$294M	$241M
Total Debt (Short + Long-Term)	$1.8B	$1.9B	$2.1B	$1.3B	$1.2B	$1.4B	$866M	$834M	$341M	$831M	$412M	$266M	$355M	$355M	$337M	$303M	$301M	$138M	$224M	$20M	$1M
Total Shareholders' Equity	$2.4B	$2.5B	$1.8B	$1.4B	$1.1B	$1.1B	$961M	$907M	$905M	$734M	$693M	$733M	$772M	$850M	$707M	$625M	$527M	$419M	$312M	$259M	$191M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BRKR viewer.

BRKR Metric Deep Dives

Other Companies in MEDICAL DEVICES

BIO · Bio-Rad Laboratories Inc — $10 billion
GMED · Globus Medical — $10 billion
BIO.B · Bio-Rad Laboratories Inc — $10 billion
GKOS · Glaukos Corp — $10 billion
HAE · Haemonetics Corporation — $5 billion
ITGR · Integer Holdings Corp — $4 billion
LIVN · LivaNova PLC — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← BRKN All “B” companies BRKU →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.